Summary of the ZepBound Subsection (Mini-List) Dual GIP and GLP-1 receptor agonist approved for weight management Provides strong appetite suppression and craving reduction Leads to some of the largest weight loss outcomes among modern medications Improves insulin sensitivity and metabolic health Ideal for patients needing powerful, once-weekly metabolic support Why We Do Not Use Compounded Weight Loss Medications Compounded versions of semaglutide, tirzepatide, or similar medications have become widely advertised by online clinics, medspas, and cash-pay weight loss programs
So which weight loss injection works best
Although Semaglutide GLP-1 is effective, it may cause mild to moderate side effects, primarily gastrointestinal symptoms
Ozempic (injectable, weekly, 0.25mg, 0.5mg, 1.0mg, 2.0mg) and Rybelsus (oral, daily, 7mg, 14mg) are FDA-approved for type 2 diabetes, while Wegovy (injectable, weekly, 0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg) is approved for obesity